Figures
- FIGURE 1
Proportion of patients who develop chronic thromboembolic pulmonary hypertension (CTEPH) following pulmonary embolism (PE). #: studies followed-up individual patients after PE.
- FIGURE 2
a) Annual diagnosed incidence of pulmonary embolism (PE), and b) annual full incidence of chronic thromboembolic pulmonary hypertension (CTEPH) per 100 000 population in Europe, the USA and Japan (crude rates for the year 2015).
- FIGURE 3
Distribution of patients with chronic thromboembolic pulmonary hypertension by New York Heart Association functional class (NYHA FC) at time of diagnosis by region. EU: European Union.
- FIGURE 4
Proportions of patients with chronic thromboembolic pulmonary hypertension (CTEPH) who were diagnosed in Europe, the USA and Japan in 2013.
Tables
- TABLE 1
Projected estimates of the annual incidence of full and diagnosed cases of chronic thromboembolic pulmonary hypertension (CTEPH) in Europe, the USA and Japan
2015 2025 Full incidence of CTEPH Diagnosed incidence of CTEPH Full incidence of CTEPH Diagnosed incidence of CTEPH France 3310 650 3744 1154 Germany 3879 674 4065 934 Italy 2747 529 2975 905 Spain 1603 133 1833 357 UK 2087 617 2347 956 USA 16 566 2000 19 531 4543 Japan 2444 732 2513 1356 Total 32 636 5334 37 009 10 205 NYHA FC III/IV 3860 6393 Data are presented as n. NYHA FC: New York Heart Association functional class.
Supplementary Material
Please note: supplementary material is not edited by the Editorial Office, and is uploaded as it has been supplied by the author.
Supplementary table S1, and figures S1 and S2 ERR-0121-2016_Supplementary_data
Supplementary Material
W. Cacheris ERR-0121-2016_Cacheris
H. Gall ERR-0121-2016_Gall
B. Hinzmann ERR-0121-2016_Hinzmann
M.M. Hoeper ERR-0121-2016_Hoeper
E. Mayer ERR-0121-2016_Mayer
M.J. Richter ERR-0121-2016_Richter
